Market News

Latest financial and economic news and analysis

Newsfile Corp News Agency
4 days agoNewsfile Corp
Stocks Medium Importance Neutral
ADMA BIOLOGICS DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages ADMA Biologics, Inc. Investors to Secure Counsel Before Important August 10 Deadline in Securities Class Action First Filed by the Firm - ADMA

ADMA BIOLOGICS DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages ADMA Biologics, Inc. Investors to Secure Counsel Before Important August 10 Deadline in Securities Class Action First Filed by the Firm - ADMA

New York, New York--(Newsfile Corp. - August 8, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of ADMA Biologics, Inc. (NASDAQ: ADMA) between August 9, 2024 and March 25, 2026, both dates inclusive (the "Class Period"), of the important August 10, 2026 lead plaintiff deadline in the securities class action first filed by the Firm. SO WHAT: If you purchased ADMA Biologics securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

Related Symbols 1
ADMA ADMA
Source: Newsfile Corp
Visit Source
Comment
Newsfile Corp News Agency
4 days agoNewsfile Corp
Stocks Medium Importance Neutral
EMBECTA DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Embecta Corp. Investors to Secure Counsel Before Important August 17 Deadline in Securities Class Action - EMBC

EMBECTA DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Embecta Corp. Investors to Secure Counsel Before Important August 17 Deadline in Securities Class Action - EMBC

New York, New York--(Newsfile Corp. - August 8, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Embecta Corp. (NASDAQ: EMBC) between November 25, 2025 and May 4, 2026, inclusive (the "Class Period"), of the important August 17, 2026 lead plaintiff deadline. SO WHAT: If you purchased Embecta common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

Related Symbols 1
EMBC EMBC
Source: Newsfile Corp
Visit Source
Comment
Seeking Alpha News Agency
4 days agoSeeking Alpha
Stocks Medium Importance Neutral
Microsoft Corporation: A Buy And Hold Forever Type Of Stock

Microsoft Corporation: A Buy And Hold Forever Type Of Stock

Microsoft Corporation remains a strong buy, especially on modest pullbacks, given its history of growth and cash flow generation. Microsoft's recent rally followed an earnings call that dispelled over-pessimism, with the stock outperforming the market by approximately 14% since the last upgrade. Cloud revenue acceleration and an overlooked gaming segment are driving near-term upside, while valuation remains attractive relative to historical highs.

Source: Seeking Alpha
Visit Source
Comment
Crypto Briefing News Agency
4 days agoCrypto Briefing
Cryptocurrency Medium Importance Neutral
Strategy raises $15B using AI-designed financing tools to fuel Bitcoin buying spree

Strategy raises $15B using AI-designed financing tools to fuel Bitcoin buying spree

AI-driven financial innovation could reshape corporate strategies, but heavy reliance on volatile assets like Bitcoin poses significant risks. Strategy raises $15B using AI-designed financing tools to fuel Bitcoin buying spree.

Related Symbols 1
Source: Crypto Briefing
Visit Source
Comment
Coinspress News Agency
4 days agoCoinspress
Cryptocurrency Medium Importance Neutral
Bitcoin and Ethereum ETFs Lead $1.1B Weekly Crypto Fund Inflows

Bitcoin and Ethereum ETFs Lead $1.1B Weekly Crypto Fund Inflows

Institutional investors continued to favor Bitcoin and Ethereum exchange-traded funds during the August 3-7 trading week, directing more than $1.1 billion into the two largest digital assets while newer crypto ETFs tied to Solana, XRP and Hyperliquid struggled to attract meaningful capital.

Related Symbols 1
Source: Coinspress
Visit Source
Comment
MarketBeat News Agency
4 days agoMarketBeat
Stocks Medium Importance Neutral
Globus Medical Q2 Earnings Call Highlights

Globus Medical Q2 Earnings Call Highlights

Globus Medical NYSE: GMED reported second-quarter 2026 revenue of $789.6 million, up 6% from a year earlier, as growth in its spine and trauma businesses helped offset declines in enabling technologies and Nevro sales. The company reaffirmed its full-year revenue outlook while raising its adjusted earnings forecast, citing margin expansion and operating leverage in the first half.

Related Symbols 1
GMED GMED
Source: MarketBeat
Visit Source
Comment
MarketBeat News Agency
4 days agoMarketBeat
Stocks Medium Importance Neutral
Genco Shipping & Trading Q2 Earnings Call Highlights

Genco Shipping & Trading Q2 Earnings Call Highlights

Genco Shipping & Trading NYSE: GNK reported stronger second-quarter results as dry bulk freight rates rose, supported by higher earnings from its expanded fleet and a continued focus on low leverage and shareholder dividends.

Related Symbols 1
GNK GNK
Source: MarketBeat
Visit Source
Comment
MarketBeat News Agency
4 days agoMarketBeat
Stocks Medium Importance Neutral
Global Net Lease Q2 Earnings Call Highlights

Global Net Lease Q2 Earnings Call Highlights

Global Net Lease NYSE: GNL reported second-quarter 2026 revenue of $112.5 million, a net loss attributable to common stockholders of $7.5 million and adjusted funds from operations (AFFO) of $45.7 million, or $0.22 per share. AFFO per share increased from $0.21 in the first quarter, while the company raised its full-year outlook following its pending acquisition of Modiv Industrial.

Related Symbols 1
GTLL GTLL
Source: MarketBeat
Visit Source
Comment
MarketBeat News Agency
4 days agoMarketBeat
Stocks Medium Importance Neutral
Genworth Financial Q2 Earnings Call Highlights

Genworth Financial Q2 Earnings Call Highlights

Genworth Financial NYSE: GNW reported second-quarter net income of $47 million, or $0.12 per share, while adjusted operating income excluding its closed block business totaled $112 million, or $0.29 per share. The company's results were led by mortgage insurance subsidiary Enact, while losses in the closed block and continued investment in CareScout weighed on overall performance.

Related Symbols 1
GNW GNW
Source: MarketBeat
Visit Source
Comment
MarketBeat News Agency
4 days agoMarketBeat
Stocks Medium Importance Neutral
Acushnet Q2 Earnings Call Highlights

Acushnet Q2 Earnings Call Highlights

Acushnet NYSE: GOLF reported higher second-quarter sales and adjusted EBITDA, citing continued momentum in Titleist golf equipment, an accelerated launch of its GTS metals line and a benefit from tariff refunds. The company also raised its full-year outlook, though it expects second-half comparisons to be affected by the timing of golf-club shipments and preparation for a 2027 Pro V1 launch.

Related Symbols 1
GOLF GOLF
Source: MarketBeat
Visit Source
Comment